Literature DB >> 17108318

International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality.

Maki Yoshino1, Martin K Kuhlmann, Peter Kotanko, Roger N Greenwood, Ronald L Pisoni, Friedrich K Port, Kitty J Jager, Peter Homel, Hans Augustijn, Frank T de Charro, Frederic Collart, Ekrem Erek, Patrik Finne, Guillermo Garcia-Garcia, Carola Grönhagen-Riska, George A Ioannidis, Frank Ivis, Torbjorn Leivestad, Hans Løkkegaard, Frantisek Lopot, Dong-Chan Jin, Reinhard Kramar, Toshiyuki Nakao, Mooppil Nandakumar, Sylvia Ramirez, Frank M van der Sande, Staffan Schön, Keith Simpson, Rowan G Walker, Wojciech Zaluska, Nathan W Levin.   

Abstract

Existing national, racial, and ethnic differences in dialysis patient mortality rates largely are unexplained. This study aimed to test the hypothesis that mortality rates related to atherosclerotic cardiovascular disease (ASCVD) in dialysis populations (DP) and in the background general populations (GP) are correlated. In a cross-sectional, multinational study, all-cause and ASCVD mortality rates were compared between GP and DP using the most recent data from the World Health Organization mortality database (67 countries; 1,571,852,000 population) and from national renal registries (26 countries; 623,900 population). Across GP of 67 countries (14,082,146 deaths), all-cause mortality rates (median 8.88 per 1000 population; range 1.93 to 15.40) were strongly related to ASCVD mortality rates (median 3.21; range 0.53 to 8.69), with Eastern European countries clustering in the upper and Southeast and East Asian countries in the lower rate ranges. Across DP (103,432 deaths), mortality rates from all causes (median 166.20; range 54.47 to 268.80) and from ASCVD (median 63.39 per 1000 population; range 21.52 to 162.40) were higher and strongly correlated. ASCVD mortality rates in DP and in the GP were significantly correlated; the relationship became even stronger after adjustment for age (R(2) = 0.56, P < 0.0001). A substantial portion of the variability in mortality rates that were observed across DP worldwide is attributable to the variability in background ASCVD mortality rates in the respective GP. Genetic and environmental factors may underlie these differences.

Entities:  

Mesh:

Year:  2006        PMID: 17108318     DOI: 10.1681/ASN.2006020156

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  37 in total

1.  Elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients.

Authors:  Tetsuo Shoji; Ikuto Masakane; Yuzo Watanabe; Kunitoshi Iseki; Yoshiharu Tsubakihara
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 8.237

Review 2.  End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF).

Authors:  Avi Dor; Mark V Pauly; Margaret A Eichleay; Philip J Held
Journal:  Int J Health Care Finance Econ       Date:  2007-09

3.  Dialysis modality after renal transplant failure.

Authors:  Clare Castledine; Fergus J Caskey
Journal:  Perit Dial Int       Date:  2013 Nov-Dec       Impact factor: 1.756

4.  Dialysis: Some patients may benefit from using high-flux membranes.

Authors:  Victor F Seabra; Jacob J Clarenbach; Bertrand L Jaber
Journal:  Nat Rev Nephrol       Date:  2009-08       Impact factor: 28.314

Review 5.  High blood pressure in dialysis patients: cause, pathophysiology, influence on morbidity, mortality and management.

Authors:  Aaron Stern; Soumya Sachdeva; Rohit Kapoor; Jasjit Singh; Sarthak Sachdeva
Journal:  J Clin Diagn Res       Date:  2014-06-20

6.  Trends in Renal Replacement Therapy in Bosnia and Herzegovina 2002-2008.

Authors:  Halima Resić; Enisa Mesić
Journal:  Bosn J Basic Med Sci       Date:  2010-04       Impact factor: 3.363

7.  Responsiveness to erythropoiesis-stimulating agents in chronic kidney disease: does geography matter?

Authors:  Luca De Nicola; Francesco Locatelli; Giuseppe Conte; Roberto Minutolo
Journal:  Drugs       Date:  2014-02       Impact factor: 9.546

Review 8.  Reducing hospital readmissions in patients with end-stage kidney disease.

Authors:  Anna T Mathew; Giovanni F M Strippoli; Marinella Ruospo; Steven Fishbane
Journal:  Kidney Int       Date:  2015-10-14       Impact factor: 10.612

9.  Association of pre-transplant dialysis duration with outcome in kidney transplant recipients: a prevalent cohort study.

Authors:  Adam Remport; Andras Keszei; Eszter Panna Vamos; Marta Novak; Jeno Jaray; Laszlo Rosivall; Istvan Mucsi; Miklos Zsolt Molnar
Journal:  Int Urol Nephrol       Date:  2010-01-08       Impact factor: 2.370

10.  Effect of membrane permeability on survival of hemodialysis patients.

Authors:  Francesco Locatelli; Alejandro Martin-Malo; Thierry Hannedouche; Alfredo Loureiro; Menelaos Papadimitriou; Volker Wizemann; Stefan H Jacobson; Stanislaw Czekalski; Claudio Ronco; Raymond Vanholder
Journal:  J Am Soc Nephrol       Date:  2008-12-17       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.